Navigation Links
Foundation Venture Capital Group Commits Second Round of Funding to Actinobac Biomed
Date:2/21/2013

NEW BRUNSWICK, N.J., Feb. 21, 2013 /PRNewswire-USNewswire/ -- Actinobac Biomed, Inc., has received a commitment for a second investment of $100,000 from Foundation Venture Capital Group (FVCG) to  study the efficacy of the company's lead product, Leukothera®, in  the treatment of  veterinary white blood cell diseases , announced Dr. George F. Heinrich , vice chair and CEO of FVCG.

FVCG had originally invested $500,000 when Actinobac was first established in 2009 to develop pharmaceutical agents for the treatment of hematologic malignancies (leukemias & lymphomas), latent infections (HIV/AIDS & tuberculosis) and autoimmune diseases (rheumatoid arthritis, multiple sclerosis, Crohn's disease, type 1 diabetes, Lupus & psoriasis).

Leukothera® is a bacterial toxin that specifically targets and depletes disease related white blood cells (WBC). In laboratory studies to date, malignant and proinflammatory white blood cells have been determined to be more sensitive to Leukothera® than normal white blood cells. Animal studies carried out by Actinobac have shown Leukothera™ to possess significant therapeutic activity.

"We are contracting with Texas A&M Veterinary School to examine the use of Leukothera® for dogs suffering with white blood cell diseases," explained company founder Dr. Scott Kachlany.  "Because of biological similarities, the data we obtain from these new studies will be applicable to dogs and support drug development for human applications also."

The latest $100,000 investment will fund proof of concept studies. According to Dr. Kachlany, early results indicate that Actinobac's drug candidate works very well in healthy dogs, using lower doses than previously expected.

"We are excited about Dr. Kachlany's results to date," explained James M. Gol
'/>"/>

SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Simbionix firma un acuerdo con la Laparoscopic Surgical Skills Foundation (LSS)
2. Simbionix Signs an Agreement with the Laparoscopic Surgical Skills Foundation (LSS)
3. The Michael J. Fox Foundation Launches New Funding Opportunities for Parkinsons Research
4. National Patient Advocate Foundation Supports 340B Drug Discount Program Review Identifying Risks to Underinsured Patients
5. Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
6. Se crea en Taiwán la Tang Prize Foundation
7. Tang Prize Foundation Established in Taiwan: Academia Sinica to be Responsible for the Nomination and Selection of the International Awards in Taiwan
8. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
9. Asthma and Allergy Foundation of America Challenges Patients and Caregivers to Get Smart About Asthma
10. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
11. UCB, Inc. and Arthritis Foundation Partner to Celebrate the "Everyday Victories" of the Rheumatoid Arthritis Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013 Attorney Advertising -- Bronstein, Gewirtz & ... of purchasers of the securities of AMAG Pharmaceuticals, ... The investigation focuses on whether the Company and ... On May 22, 2013, Shares of AMAG dropped ... company announced in regulatory filing that it has ...
(Date:5/22/2013)... and MUNICH , May 22, 2013 /PRNewswire/ ... marketer of transcatheter aortic valve implantation (TAVI) systems for the ... results of the J enaValve Eval U ation of ... Pa T ients with S E vere Ao R tic ... . JUPITER is a post-market registry to evaluate five-year long ...
(Date:5/22/2013)... May 22, 2013 The new 13-valent pneumococcal ... the previous version used prior to 2010, the 7-valent ... study published today in Vaccine. The U.S. ... in 2010 after a series of trials. These trials ... of pneumococcal types than the previously used PCV7, did ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4
... Progen,Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) today announced ... PI-88 as an adjuvant,treatment for primary liver cancer ... patient having been randomized,onto the study. The study ... treatment of HCC). The first patient to enter ...
... SILVER SPRING, Md., March 11 In a boost ... to provide a,royalty-free license to the non-profit International Partnership ... use as a,potential vaginal microbicide., The compound, called ... known as gp41 fusion inhibitors, which inhibit HIV infection ...
Cached Medicine Technology:Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer 2Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer 3Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer 4Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 2Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 3
(Date:5/22/2013)... On a Saturday morning last summer, MSgt. Joe DesLauriers ... Bourne Legacy” at the White Flint Mall movie theater in ... activity to many couples, it is a pure luxury for ... everyday reality has become possible through the Military Family Respite ... , Life changed for the DesLauriers family on Sept. 23, ...
(Date:5/22/2013)... York, New York (PRWEB) May 22, 2013 ... the nation’s first trial involving a da Vinci lawsuit, ... the case, the family of a man who allegedly died ... seeking more than $8 million in damages from Intuitive Surgical, ... down its physician training program for the da Vinci Surgical ...
(Date:5/22/2013)... Nearly 50,000 veterans appeals were received ... year 2012, with even more—54,033—expected by fiscal year-end 2013. ... decision as the agency reports reduced decisions and a ... disability appeal services. The BVA is an agency ... the BVA received 49,611 cases in FY 2012, it ...
(Date:5/22/2013)... CORVALLIS, Ore. A new study shows there is ... self-control in American young children one that does ... In the United States, girls had higher levels of ... to control their behavior and impulses, follow directions, and ... academic performance and college completion, in past studies by ...
(Date:5/22/2013)... May 22, 2013 Successful Therapy ... Patricia O’Laughlin Psychotherapy in the Silver Lake community ... all ages as progression to existing Parents and ... ages into parenting therapy has always been suggested, ... O’Laughlin Psychotherapy now specializes in all aspects of ...
Breaking Medicine News(10 mins):Health News:Military Family Finds Respite with Easter Seals 2Health News:Military Family Finds Respite with Easter Seals 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2
... 28, 2008 -- WASHINGTON, DC) The American ... Foundation (CRF) announced today a multi-year partnership to ... in Orlando, Fla., March 2831, 2009, during ACC.09, ... worlds premier cardiovascular meeting. This will be ...
... Wins First Canadian Golf Tour Title While Wearing Surgex(TM) Branded ... ... virus and a late bogey to capture his first Canadian Tour title,at the ... victory places the former University of Texas standout in prime,position to qualify for ...
... acid molecules fabricated in the laboratory have been shown ... 1 diabetes in animal models. The results of these ... G. Rangos Sr. Research Center at Childrens Hospital of ... a research study at Childrens Hospital, the scientists injected ...
... ("DRAXIS"),(TSX: DAX) (NASDAQ: DRAX ) announced today the ... common shares have been acquired by,an indirect wholly-owned subsidiary ... a result, DRAXIS common stock is expected to cease,trading ... Stock Exchange at,market close on Thursday, May 29, 2008, ...
... in the May 28, 2008 edition of The Journal ... action of certain brain cells altered by chronic alcohol ... the central amygdala, which plays an important role in ... alcohol drinking. In the study, alcohol-dependent rodents receiving gabapentin ...
... being,issued by the National Academy of Social Insurance:, ... 3:30 pm Seminar: Growing Risks for Workers and Growing ... from Behavioral Economics to Control Health Costs, Peter ... Benefits, Stephen C. Goss, Chief Actuary of the ...
Cached Medicine News:Health News:ACC and CRF announce partnership on ACC's Innovation in Intervention: i2 Summit 2Health News:Surgex(TM) Fuels 2008 San Luis Potosi Open Champion Russell Surber Through Grueling 36 Hole Final Day 2Health News:Surgex(TM) Fuels 2008 San Luis Potosi Open Champion Russell Surber Through Grueling 36 Hole Final Day 3Health News:New vaccine approach prevents/reverses diabetes in lab study at Children's Hospital of Pittsburgh 2Health News:New vaccine approach prevents/reverses diabetes in lab study at Children's Hospital of Pittsburgh 3Health News:DRAXIS Announces Completion of Sale to Jubilant 2Health News:DRAXIS Announces Completion of Sale to Jubilant 3Health News:DRAXIS Announces Completion of Sale to Jubilant 4Health News:Scripps Research scientists find seizure drug reverses cellular effects 2
Used where access is required into superior meniscal flap region....
This family of punches offers the best of both worlds the lowest profile and the largest bite, facilitating end-on and lateral cutting the most versatile instrument available....
The narrow shaft and compact jaw design facilitates access and use in tight spaces, particularly useful in the posterior aspect of the knee....
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
Medicine Products: